Mixed results after autologous stem-cell transplantation for STEMI
Kate Matthews
This article has no abstract so we have provided the first paragraph of the full text.
Despite the benefit of reperfusion therapies, ST-segment elevation myocardial infarction (STEMI) is associated with a loss of viable myocardium and left ventricular (LV) function. Intracoronary transfer of autologous stem cells from bone marrow might improve LV remodeling and function following STEMI, but trials investigating this procedure have not included appropriate placebo control groups. Janssens and coauthors compared the effects of intracoronary stem-cell transfer with those of placebo transfer.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
